Armistice Capital »

Surrozen shares owned by Armistice Capital

Quarter-by-quarter ownership of Surrozen (SRZN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Surrozen

Tip: Access up to 7 years of quarterly data

All positions including Surrozen held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Surrozen by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.1M 190k 10.95

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Surrozen

RA Capital Management
Alyeska Investment Group
Armistice Capital
Nantahala Capital Management
Stempoint Capital
Euclidean Capital
Stonepine Capital Management
CVI Holdings
Vanguard Group
Arrowpoint Asset Management
Board of Trustees of The Leland Stanford Junior University
Morgan Stanley
Geode Capital Management
Renaissance Technologies
BlackRock

View all funds holding Surrozen